Almatis Commit to Full-Scale Production of Calcined Specialty Alumina Products

Almatis announced today that it is establishing a full-scale calcines production facility in China, bringing the total investment into the production and processing of calcined specialty alumina products in the region to USD 50 million.

The new plant will be integrated with the existing Huangdao (Qingdao) tabular operation. The first phase of the project, a batch mill, will start production by the end of 2008. The kiln and other downstream processing equipment are scheduled to come on-stream by mid-2010.

This investment positions Almatis strategically to continue meeting the rising demand of customers in South East Asia for premium alumina products. China remains the world’s largest steel producing nation and there is significant growth potential in the Asian markets in ceramic applications such as flat panel displays, spark plugs and electronic substrates.

“This decision represents a major commitment to supporting our customers’ future growth. We are investing our resources in this large project at a time when the global economic outlook is uncertain and our industry has to cope with massive increases of key input factor cost such as feedstock, energy and transportation. We see however the need for further investment to ensure sufficient availability of premium specialty alumina as enablers of growth in a range of industries”, comments Martin Laudenbach, Almatis’ CEO. “Our customers can furthermore expect increased flexibility and shorter delivery times as a result of the greater market proximity of the new facility and reduced dependency on long distance shipping.”

The new Asian calcines production facility complements Almatis’ existing calcines operations in North America and Europe. The project will incorporate state-of-the-art energy efficient technology for stable and efficient production.
 

For more information on calcines, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.